HCPCS Code for Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as T1-3, N1-2, M0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a Medicare-approved demonstration project) G9092
HCPCS code G9092 for Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as T1-3, N1-2, M0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a Medicare-approved demonstration project) as maintained by CMS falls under Medicare Demonstration Projects .
Subscribe to Codify by AAPC and get the code details in a flash.
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as T1-3, N1-2, M0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a Medicare-approved demonstration project)
Tabs
Match supply and drug codes in a snap. View corresponding CPT® codes and their definitions.
Tabs
Subscribers see the ICD-10-CM codes a contractor allows and full LCD policy text on the same website.
Protect Part B Payments by complying with Correct Coding Initiative (CCI) edits. Subscribers see the full list of column 2 codes for the searched HCPCS code.
Read a HCPCS Coding Clinic® article by subscribing today.